Inventor · disambiguated record
Tristan Reuillon
Also filed as: REUILLON TRISTAN
4 granted patents·4 pending applications·4 citations·filing 2015–2025
63Inventor score
Technology areasC07D
Files withUNIV COLLEGE CARDIFF CONSULTANTS LTD4JANSSEN PHARMACEUTICA NV2AVELOS THERAPEUTICS INC1CANCER RESEARCH TECH LTD1
Top patents by PatentIndex Score
8 records- 0176US11298345B2Compounds that modulates AMPA receptor functionUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2019·Granted Apr 12, 2022·1 cites·23 claims
- 0274US2025375432A1Compounds that modulates ampa receptor functionUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2025·Application pending·0 cites
- 0373US10344017B2Pyrrolcarboxamide derivatives for the inhibition of ERK5CANCER RESEARCH TECH LTD·Filed 2015·Granted Jul 9, 2019·2 cites·20 claims
- 0472US11186567B2AMPA receptor potentiatorsUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2018·Granted Nov 30, 2021·1 cites·20 claims
- 0571US12383540B2Compounds that modulates AMPA receptor functionUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2022·Granted Aug 12, 2025·0 cites·75 claims
- 0657US2024300936A1Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agentsAVELOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0750US2023250109A1Macrocyclic ether containing indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0849US2023130109A1Macrocyclic indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →